BackBellevue Life Sciences Acquisition - Warrants (09/02/2028) Overview

Bellevue Life Sciences Acquisition - Warrants (09/02/2028) Total Revenue

Revenue analysis for BLACW.

Quarterly Revenue

$484057.00
↓ 36.41% YoY

As of Mar 2026

Annual Revenue (TTM)

$2.63M
↑ 245.29% YoY

Trailing 12 months ending Mar 2026

Average Revenue (Comparison Companies)

Loading

Total Revenue History

Loading

Total Revenue Comparison

Loading

Annual Revenue Growth Rate (%)

Loading

Annual Revenue Growth (Absolute)

Loading
Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin